<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-9VN3Y83N</identifier><date>2019</date><creator>Černe, Katarina</creator><creator>Hadžialjević, Benjamin</creator><creator>Kobal, Borut</creator><creator>Škof, Erik</creator><relation>documents/doc/9/URN_NBN_SI_doc-9VN3Y83N_001.pdf</relation><relation>documents/doc/9/URN_NBN_SI_doc-9VN3Y83N_001.txt</relation><format format_type="issue">1</format><format format_type="volume">53</format><format format_type="type">article</format><format format_type="extent">str. 105-115, VIII</format><identifier identifier_type="DOI">10.2478/raon-2019-0003</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">5740972</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-9VN3Y83N</identifier><language>eng</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">ascites</subject><subject language_type_id="slv">diagnostika</subject><subject language_type_id="slv">jajčniki</subject><subject language_type_id="slv">osteopontin</subject><subject language_type_id="slv">rak (medicina)</subject><title>Potential of osteopontin in the management of epithelial ovarian cancer</title></Record>